Churchill Capital Corp XI - Class A Ordinary Shares (NQ:CCXI)

10.22 -0.03 (-0.29%)

Delayed Quote Updated: 1:01 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Churchill Capital Corp XI - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

August 02, 2021

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...

Via Benzinga

Analyzing ChemoCentryx's Unusual Options Activity ↗

July 29, 2021

ChemoCentryx (NASDAQ:CCXI) shares experienced unusual options activity on Thursday. The stock price moved down to $15.19 following the option alert. Sentiment: BULLISH Option...

Via Benzinga

2 Beaten-Down Biotech Stocks That Could Bounce Back ↗

July 27, 2021

The market hasn't been kind to these two drugmakers, but both have a chance to turn things around.

Via The Motley Fool

The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix ↗

July 11, 2021

Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow. On the drug approval front, Provention Bio, Inc. (NASDAQ: PRVB) faced a setback...

Via Benzinga

Analyst Ratings For ChemoCentryx ↗

July 07, 2021

Analysts have provided the following ratings for ChemoCentryx (NASDAQ:

Via Benzinga

Why This ChemoCentryx Analyst Is Bullish ↗

July 06, 2021

H.C. Wainwright analysts remain bullish on ChemoCentryx, Inc. (NASDAQ:

Via Benzinga

Is Now the Time to Buy ChemoCentryx Stock? ↗

July 10, 2021

Analysts following this risky biotech stock have changed their tune.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2021 ↗

July 07, 2021

Upgrades According to Raymond James, the prior rating for Sunnova Energy International Inc (N...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

July 07, 2021

Keybanc cut Alibaba Group Holding Limited (NYSE: BABA) price target from $275 to $270. Alibaba shares rose 0.5% to $212.60 in pre-market trading. Needham boosted SMART Global...

Via Benzinga

ChemoCentryx Stock Is Approaching A Key Level ↗

July 06, 2021

ChemoCentryx Inc. (NASDAQ: CCXI) shares traded higher Tuesday after the company announced it filed an amendment to its New Drug Application for avacopan for the treatment of anti-...

Via Benzinga

ChemoCentryx Stock Jumps On Amendment In Avacopan Application, New Goal Date Of October 7 ↗

July 06, 2021

Following consultations with the FDA, ChemoCentryx Inc (NASDAQ: CCXI) filed an amendment to its marketing application seeking approval for avacopan to treat...

Via Benzinga

Biotech Losers In 2021 That Could Bounce Big In The Second Half ↗

July 03, 2021

Biotech stocks are tricky investment bets that require careful analysis and scrutiny. Here's a list of biotech stocks that were among the worst performers in the first half but have the potential to...

Via Talk Markets

Biotech Losers In 2021 That Could Bounce Big In The Second Half ↗

July 03, 2021

Biotech stocks are tricky investment bets that require careful analysis and scrutiny. A stock that has fallen off a cliff in reaction to a binary event can neither be written off...

Via Benzinga

CCXI DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of ChemoCentryx, Inc. of Deadline in Securities Fraud Class Action Lawsuit

July 03, 2021

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision, Conference Presentations In A Light Week ↗

July 03, 2021

Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the year. The week witnessed a few...

Via Benzinga

CHEMOCENTRYX 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against ChemoCentryx, Inc. - CCXI

July 02, 2021

From Kahn Swick & Foti, LLC

Via Business Wire

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against ChemoCentryx, Inc. and Encourages Investors to Contact the Firm

July 02, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

Is It Too Late to Buy ChemoCentryx Stock? ↗

July 02, 2021

This biotech is traveling in uncharted waters.

Via The Motley Fool

Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates ↗

July 01, 2021

June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive...

Via Benzinga

CCXI CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against ChemoCentryx, Inc.

June 30, 2021

NEW YORK, NY / ACCESSWIRE / June 30, 2021 / Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class...

From Bernstein Liebhard LLP

Via AccessWire

Topics Lawsuit

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI)

June 30, 2021

From The Law Offices of Frank R. Cruz

Via Business Wire

CCXI Approaching Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds ChemoCentryx, Inc. Investors of Class Action and Lead Plaintiff Deadline: July 6, 2021

June 30, 2021

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

TUESDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 30, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

7-DAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 29, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

NASDAQ:CCXI Investor Notice: Deadline on July 6, 2021 in Lawsuit Against ChemoCentryx, Inc. ↗

June 28, 2021

San Diego, CA -- (SBWIRE) -- 06/28/2021 -- A deadline is coming up on July 6, 2021 in the lawsuit filed for certain investors of ChemoCentryx, Inc. (NASDAQ:CCXI).

Via SBWire

Topics Lawsuit

UPCOMING DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 28, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 25, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 24, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

UPCOMING DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 23, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Is ChemoCentryx a Buy? ↗

June 23, 2021

Next month is sure to be a big one for the company, with the FDA slated to make a decision on its most advanced drug, avacopan.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.